Beauty Health (NASDAQ:SKIN) Sets New 52-Week Low at $9.51

The Beauty Health Company (NASDAQ:SKINGet Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $9.51 and last traded at $9.99, with a volume of 69906 shares changing hands. The stock had previously closed at $11.30.

Analyst Upgrades and Downgrades

SKIN has been the topic of several recent analyst reports. DA Davidson upped their price objective on shares of Beauty Health from $31.00 to $32.00 and gave the company a “buy” rating in a research note on Wednesday. Piper Sandler upped their price target on shares of Beauty Health from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Friday, September 16th. JPMorgan Chase & Co. lowered shares of Beauty Health from an “overweight” rating to a “neutral” rating and dropped their price target for the stock from $22.00 to $11.00 in a research report on Wednesday. Finally, The Goldman Sachs Group dropped their price target on shares of Beauty Health from $25.00 to $22.00 and set a “buy” rating for the company in a research report on Tuesday, August 16th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, Beauty Health has a consensus rating of “Moderate Buy” and an average target price of $21.57.

Beauty Health Stock Down 21.1 %

The firm’s 50-day moving average price is $11.86 and its 200-day moving average price is $12.55. The company has a quick ratio of 10.59, a current ratio of 11.44 and a debt-to-equity ratio of 2.08.

Beauty Health (NASDAQ:SKINGet Rating) last released its quarterly earnings data on Tuesday, August 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.10). Beauty Health had a negative return on equity of 1.02% and a negative net margin of 59.08%. The business had revenue of $103.54 million during the quarter, compared to analyst estimates of $85.70 million. Research analysts anticipate that The Beauty Health Company will post 0.05 EPS for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

Large investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC grew its holdings in Beauty Health by 88.9% during the 3rd quarter. Nisa Investment Advisors LLC now owns 4,490 shares of the company’s stock valued at $52,000 after purchasing an additional 2,113 shares in the last quarter. Amundi acquired a new stake in Beauty Health during the 2nd quarter valued at $92,000. Ensign Peak Advisors Inc acquired a new stake in Beauty Health during the 2nd quarter valued at $107,000. Millennium Management LLC acquired a new stake in Beauty Health during the 2nd quarter valued at $132,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Beauty Health during the 2nd quarter valued at $136,000. Institutional investors and hedge funds own 78.59% of the company’s stock.

Beauty Health Company Profile

(Get Rating)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.

Featured Stories

Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.